Bach Flower Remedies for pain relief and psychological problems



Similar documents
Aromatherapy for pain relief and psychological problems

33 % of whiplash patients develop. headaches originating from the upper. cervical spine

Drugs for MS.Drug fact box cannabis extract (Sativex) Version 1.0 Author

If several different trials are mentioned in one publication, the data of each should be extracted in a separate data extraction form.

Prepared by:jane Healey ( 4 th year undergraduate occupational therapy student, University of Western Sydney

Guidance on Investigational Medicinal Products (IMPs) and other medicinal products used in Clinical Trials

TITLE: Cannabinoids for the Treatment of Post-Traumatic Stress Disorder: A Review of the Clinical Effectiveness and Guidelines

Can I have FAITH in this Review?

Summary HTA. Interferons and Natalizumab for Multiple Sclerosis Clar C, Velasco-Garrido M, Gericke C. HTA-Report Summary

Managing depression after stroke. Presented by Maree Hackett

Comorbid Conditions in Autism Spectrum Illness. David Ermer MD June 13, 2014

Best supportive care: Do we know what it is?

Summary HTA. HTA-Report Summary. Introduction

Choosing a placebo EAPC Research Forum Trondheim 2008

Breast cancer treatment for elderly women: a systematic review

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) NOTE FOR GUIDANCE ON CLINICAL INVESTIGATION OF MEDICINAL PRODUCTS IN THE TREATMENT OF DEPRESSION

BEST in MH clinical question-answering service

MIND-BODY THERAPIES FOR HYPERTENSION

Behavioral and Physical Treatments for Tension-type and Cervicogenic Headache

Bio-Identical Hormone FAQ s

CRITICALLY APPRAISED PAPER (CAP)

Cochrane Review: Psychological treatments for depression and anxiety in dementia and mild cognitive impairment

MRC Autism Research Forum Interventions in Autism

Sponsor Novartis Pharmaceuticals

Identifying and Prioritizing Research Gaps. Tim Carey, M.D., M.P.H. Amica Yon, Pharm.D. Chris Beadles, M.D. Roberta Wines, M.P.H.

Version History. Previous Versions. Drugs for MS.Drug facts box fampridine Version 1.0 Author

LEVEL ONE MODULE EXAM PART ONE [Clinical Questions Literature Searching Types of Research Levels of Evidence Appraisal Scales Statistic Terminology]

Austen Riggs Center Patient Demographics

PCORI Methodology Standards: Academic Curriculum Patient-Centered Outcomes Research Institute. All Rights Reserved.

Bibliographical information. Date: Republished electronically by the Bach Flower Research Programme 2003.

Which injectable medication should I take for relapsing-remitting multiple sclerosis?

1.0 Abstract. Title: Real Life Evaluation of Rheumatoid Arthritis in Canadians taking HUMIRA. Keywords. Rationale and Background:

DEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource

Is electrotherapy more effective than other physical therapy approaches in reducing pain and disability in adults with supraspinatus tendonitis?

Version History. Previous Versions. Drugs for MS.Drug facts box fingolimod Version 1.0 Author

Sativex. Spirella Building, Letchworth, SG6 4ET reg charity no

Positive psychology in practice

BEST in MH clinical question-answering service

Self-Check and Review Chapter 1 Sections

10. Treatment of peritoneal dialysis associated fungal peritonitis

The Pharmacological Management of Cancer Pain in Adults. Clinical Audit Tool

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP)

Database of randomized trials of psychotherapy for adult depression

Glossary of Clinical Trial Terms

University of Hawai i Human Studies Program. Guidelines for Developing a Clinical Research Protocol

Integrative Therapies and Preconception Health. Debbie Ringdahl DNP, RN, CNM

Oral Zinc Supplementation as an Adjunct Therapy in the Management of Hepatic Encephalopathy: A Randomized Controlled Trial

Interferons (Avonex, Betaferon, Rebif ) for relapsing remitting multiple sclerosis (RRMS)

Medication Policy Manual. Topic: Aubagio, teriflunomide Date of Origin: November 9, 2012

RESEARCH OBJECTIVE/QUESTION

Naltrexone Shared Care Guideline for the treatment of alcohol dependence and opioid dependance

NURSES ATTITUDES TOWARDS DEPRESSION: A STUDY IN SLOVENIA

Clinical Study Synopsis

PROTOCOL SYNOPSIS Evaluation of long-term opioid efficacy for chronic pain

NEUROPSYCHOLOGY QUESTIONNAIRE. (Please fill this out prior to your appointment and bring it with you.) Name: Date of appointment: Home address:

Rapid Critical Appraisal of Controlled Trials

Autism Spectrum Disorders and Comorbid Behavioral Health Symptoms

ChangingPractice. Appraising Systematic Reviews. Evidence Based Practice Information Sheets for Health Professionals. What Are Systematic Reviews?

MELATONIN FOR SLEEP DISORDERS IN CHILDREN AND ADOLESCENTS WITH NEURODEVELOPMENTAL DISORDERS SHARED CARE GUIDELINES

Clinical Study Synopsis

HEALTH AND SOCIAL CARE

MINISTERIO DE SALUD PUBLICA DIRECCION PROVINCIAL DE SALUD DEL GUAYAS HOSPITAL DE INFECTOLOGIA DR. JOSE DANIEL RODRIGUEZ MARIDUEÑA Guayaquil - Ecuador

Clinical Audit: Prescribing antipsychotic medication for people with dementia

SLEEP DISTURBANCE AND PSYCHIATRIC DISORDERS

Version History. Previous Versions. Policy Title. Drugs for MS.Drug facts box Glatiramer Acetate Version 1.0 Author

Summary 1. Comparative-effectiveness

NKR 33 Urininkontinens, PICO 3: Bør kvinder med urininkontinens tilbydes behandling

Q: Rehabilitation Nursing

VITAMIN C AND INFECTIOUS DISEASE: A REVIEW OF THE LITERATURE AND THE RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PROSPECTIVE STUDY OVER 8 YEARS

School Refusal Behavior: Children Who Can't or Won't Go To School

Adoption by CHMP for release for consultation November End of consultation (deadline for comments) 31 March 2011

Multimedia Appendix 1: Systematic Review of EDC Adoption Surveys

Amphetamines Addiction

KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE

Oncology Nursing Society Annual Progress Report: 2008 Formula Grant

National Depressive and Manic-Depressive Association Constituency Survey

Evidence Service. Art Therapy. Plain language summary. Transport Accident Commission & WorkSafe Victoria

Product: Tazarotene, cream, 500 micrograms per g (0.05%) and 1.0 mg per g (0.1%), 30 g, Zorac

Obsessive Compulsive Disorder (OCD)

Stress is linked to exaggerated cardiovascular reactivity. 1) Stress 2) Hostility 3) Social Support. Evidence of association between these

Study Design. Date: March 11, 2003 Reviewer: Jawahar Tiwari, Ph.D. Ellis Unger, M.D. Ghanshyam Gupta, Ph.D. Chief, Therapeutics Evaluation Branch

Optum By United Behavioral Health Florida Medicaid Managed Medical Assistance (MMA) Level of Care Guidelines

Oncology Nursing Society Annual Progress Report: 2008 Formula Grant

How To Get Help From Inspireira

A Presentation by the American Chronic Pain Association

Tara Stevermuer (MAppStat), Centre for Health Service Development, University of Wollongong.

Adjunctive psychosocial intervention. Conditions requiring dose reduction. Immediate, peak plasma concentration is reached within 1 hour.

How to literature search

Transcription:

Bach Flower Remedies for pain relief and psychological problems Systematic Review Decision Support Document Nr. 17 ISSN online 1998-0469

Bach Flower Remedies for pain relief and psychological problems Systematic Review Vienna, February 2008

Project leader: Author: Literature search: Dr. Gerald Gartlehner Tessa Langley Dr. Walter Geiger Responsible for Contents: CONTACT INFORMATION Publisher: Ludwig Boltzmann Gesellschaft GmbH Operngasse 6/5. Stock, A-1010 Vienna http://www.lbg.ac.at/gesellschaft/impressum.php Ludwig Boltzmann Institute of Health Technology Assessment (LBI-HTA) Garnisongasse 7/20, A-1090 Vienna http://hta.lbg.ac.at/ Decision support documents of the LBI-HTA do not appear on a regular basis and serve to publicize the research results of the Ludwig Boltzmann Institute of Health Technology Assessments. Decision support documents of the LBI-HTA are only available to the public via the Internet at http://eprints.hta.lbg.ac.at : Decision Support Document Nr. 17 ISSN online 1998-0469 http://eprints.hta.lbg.ac.at/view/types/dsd.html 2008 LBI-HTA All rights reserved

Table of Contents Table of Contents... 3 Summary... 5 1 Bach flower remedies for pain and psychological problems... 7 1.1 Background... 7 1.2 Description of treatment... 7 1.3 Indication and therapeutic aim... 8 1.4 Treatment costs... 8 2 Literature search and selection... 9 2.1 PICO question... 9 2.2 Inclusion criteria... 9 2.3 Literature search... 9 2.4 Literature selection... 10 3 Assessment of the quality of the studies... 11 4 Data extraction... 13 4.1 Presentation of the study results... 13 4.2 Efficacy... 16 4.2.1 Efficacy of Bach flower remedies for examination anxiety...16 4.2.2 Efficacy of Bach flower remedies for Attention-deficit Hyperactivity Disorder...16 4.2.3 Efficacy of BFR for pain relief...17 4.3 Safety... 17 5 Strength of the Evidence... 19 6 Conclusion... 21 7 References... 23 Figures Figure 2.4-1: Depiction of the selection process (QUORUM tree)...10 Tables Table 2.2-:1 Inclusion criteria...9 Table 4.1-1 Study results...15 Table 5-1: Bach flower remedies evidence profile...20 LBI-HTA 2008 3

Summary Bach flower remedies (BFR) are a form of complementary medicine developed by Dr. Edward Bach in the 1930s. According to Bach, it is the imbalance in a patient s emotional state, rather than just physical causes, which gives rise to illness. The remedies therefore target the improvement of mood, emotional outlook and temperament, as well as personality and general disposition of patients, which in turn can affect a person s health. BFR are used for psychological problems, and it has been said that BFR have the potential to function as a therapeutic agent in pain relief. However, sceptics say that BFR are pure placebos, and that any effect must be caused by placebo or other non-specific effects. This systematic review evaluates the evidence about BFR in order to determine whether or not they are effective for pain relief and psychological problems, and how safe they are. Three randomised controlled trials are identified and included in the review. The indications covered by these studies are examination anxiety and Attention-deficit Hyperactivity Disorder (ADHD). According to the evidence, for these conditions, BFR are not more effective than placebo. There is no evidence about BFR for pain, and adverse events with BFR (i.e. the safety of BFR) are also under-reported. There is little evidence about BFR for psychological problems and pain, and the evidence that does exist is of poor quality. Extensive and good quality RCTs are required to obtain a clear picture as to whether BFR are effective for psychological problems or pain, and the risks associated with them. BFR target a patient s emotional state in order to improve their health sceptics says that BFR are merely placebos this review evaluates the evidence of BFR for pain relief and psychological problems according to the evidence, BFR are not more effective than placebo evidence insufficient and of poor quality LBI-HTA 2008 5

1 Bach flower remedies for pain and psychological problems 1.1 Background Bach flower remedies (BFR) are a form of complementary medicine developed by Dr. Edward Bach in the 1930s. According to Bach, it is the imbalance in a patient s emotional state, rather than just physical causes, which gives rise to illness. The remedies therefore target the improvement of mood, emotional outlook and temperament, as well as personality and general disposition of patients, which in turn can affect a person s health. BFR target a patient s emotional state in order to improve their health The individual patient is prescribed particular remedies depending on the problem at hand. For example, impatiens is used for impatience and irritability, mimulus for fear of known things, shyness and timidity, and olive for those that are drained of energy [1]. Thus BFR are used for psychological problems. However, according to Howard [2], a major factor in pain relief is the relief of anxiety. Thus it has been said that BFR have the potential to function as a therapeutic agent in pain relief [2]. However, sceptics say that BFR are pure placebos, and that any effect must be caused by placebo or other non-specific effects [3]. This is because flower remedies do not contain pharmacologically relevant amounts of the constituents which they originate from [4]. Proponents of the remedies believe that the remedies are more than a placebo, and that they work through the energy that is transmitted from the flowers to the remedy. Some RCTs exist to test whether BFR have an effect over and above that of a placebo. This systematic review summarizes studies which have been carried out which are concerned with the use of BFR for pain and for anxiety and similar psychological problems. A systematic review of BFR was carried out by Ernst [4] in 2002. In that review Ernst concluded that the hypothesis that flower remedies are associated with effects beyond a placebo response in not supported by data from rigorous clinical trials. sceptics says that BFR are merely placebos this review summarizes the evidence for BFR 1.2 Description of treatment There are 38 individual remedies, which are mostly made from the flowers of plants. They can be prepared in two ways. Using the sun method, flower heads are floated on the surface of water in a glass bowl and left in the sunshine. For the boiling method, the flowers are boiled. In both methods, the plant matter is then removed, the water filtered and mixed with an equal quantity of brandy [2]. The remedies can be taken orally or diluted in water, and depending on the symptoms, can be used individually or in combination with up to seven tinctures [5]. They allegedly have no effect on and are not affected by other medications, and as such can be used in conjunction with other forms of treatment [5]. 38 individual remedies BFR can be taken in conjunction with other forms of treatment LBI-HTA 2008 7

Bach Flower Remedies for pain relief and psychological problems 1.3 Indication and therapeutic aim indications and therapeutic aim The indications covered in this review are psychological problems of any kind and pain. The therapeutic aim is the alleviation or cure of these conditions. 1.4 Treatment costs costs not reported The cost of the Bach flower treatment is not reported anywhere in the literature included in this review. 8 LBI-HTA 2008

2 Literature search and selection 2.1 PICO question Are Bach Flower Remedies effective in reducing pain and improving psychological problems such as depression, ADHD (Attention-deficit hyperactivity disorder), stress and anxiety, in comparison with placebo? Are Bach Flower Remedies safe? PICO question 2.2 Inclusion criteria Table 2.2-:1 Inclusion criteria inclusion criteria Population Intervention Comparison Outcomes Study design Patients with pain. Patients with psychological problems. Any Bach Flower remedy. Placebo. Pain reduction. Improvement of psychological problems. All prospective studies with a control group. 2.3 Literature search The systematic literature search was carried out on 22.11.07 in the following databases. literature search b Medline via Ovid b Embase via Ovid b CCRCT (Cochrane Library) via Ovid b CDSR (Cochrane Library) via Ovid The search was limited to English and German language literature and covered the entire time span of the databases. After the removal of duplicates, 38 bibliographical references were available. The exact search strategy can be requested at the LBI for HTA. By means of a hand search, 16 additional references were identified, which raised the overall number of hits to 54. LBI-HTA 2008 9

Bach Flower Remedies for pain relief and psychological problems 2.4 Literature selection literature selection Overall, 54 Articles were available for the literature selection. The selection process is depicted in Figure 2.4-1. References identified in literature search: n = 54 Excluded references: n = 34 Only published as abstract: n = 1 Full text not available: n = 6 Full texts: n = 14 Full texts included: n = 3 Background literature n = 4 Full texts excluded: n = 7 1 conference summary 1 survey 1 not a study 1 letters 1 case report 1 time series 1 Italian 2 RCTs 1 Cross-over RCT Figure 2.4-1: Depiction of the selection process (QUORUM tree) 10 LBI-HTA 2008

3 Assessment of the quality of the studies The evaluation of the quality of the studies was carried out by two reviewers, independently of each other. Conflicting views were settled by means of discussion and consensus, or through the involvement of a third person. An exact list of the criteria that were used for the evaluation of the internal validity of the studies can be found in the internal manual of the LBI-HTA [6]. assessment of quality of studies carried out by two reviewers LBI-HTA 2008 11

4 Data extraction The extraction of data was carried out by one person. A second person checked the completeness and accuracy of the data. extraction of data by one person 4.1 Presentation of the study results Three RCTs [1,7,8] were included to answer the question as to whether BFR are effective in reducing psychological problems and whether they are safe. These studies looked at BFR for examination anxiety and ADHD. Studies looking at BFR for other psychological problems were not found. No studies were included to answer the question as to whether BFR are effective in reducing pain. 3 RCTs included LBI-HTA 2008 13

Data extraction Table 4.1-1 Study results Author, Year, Reference Armstrong and Ernst 2001 [1] Walach et al. 2001 [7] Pintov et al. 2005 [8] number Country United Kingdom Germany Israel Sponsor Not reported Institut fu r Grenzgebiete der Psychologie Not reported Study design RCT Cross-over RCT RCT Study quality Poor Poor Poor Number of patients 100 61 40 Lost to follow up 55 % 9.8 % 42.5 % Study population Students with examination anxiety registered to take examinations between May and July 1998 Students with examination anxiety registered to take at least two exams that two weeks apart Children with clinical diagnosis of any subtype of ADHD Patient age (years) Not reported 28 7-11 Indication for BFR Examination anxiety Examination anxiety ADHD Intervention 1-4 doses of Five Flower Remedy per day At least 4 drops of BFR suggested as efficacious for test anxiety per day Control Placebo Placebo Placebo Duration of treatment 7 days 4 weeks (two weeks before first test and 3 months two weeks before second test) Main outcome measures State-Trait Anxiety Inventory German Test Anxiety Inventory Conner s scale 4 drops of a five flower BFR 4 times per day Results Adverse events No significant difference in State anxiety score (on the night before examination most likely to cause anxiety)between experimental and placebo groups 51.5 in BFR group, 54.4 in placebo group (P=0.834) BFR: 3 subjects headaches and skin eruptions Placebo: 3 subjects vomiting before examination, hayfever symptoms, depressive mood No significant difference between experimental and placebo group for mean reduction in test anxiety 5.25 in BFR groups, 7.69 in placebo group (P = 0.55) One subject in BFR group reported adverse reactions. No significant difference in mean Conner s scores between experimental and placebo group before (16.59 in BFR group, 17.12 in placebo group) or after (11.90 in BFR group, 13.58 in placebo group) treatment (P not reported). Not reported Abbreviations: BFR: Bach Flower Remedies ADHD: Attention-deficit hyperactivity disorder LBI-HTA 2008 15

Bach Flower Remedies for pain relief and psychological problems 4.2 Efficacy studies on BFR for examination anxiety and ADHD included The populations that can be treated with BFR vary. This is reflected in that the very different indications of examination anxiety and ADHD were treated in the trials included in this review. The efficacy of BFR is evaluated for each indication. 4.2.1 Efficacy of Bach flower remedies for examination anxiety 1 RCT and 1 cross-over RCT on BFR for examination anxiety BFR found not to be more effective than placebo strength of evidence is low 1 Rct on BFR for ADHD no significant difference between BFR and placebo groups strength of evidence is very low One RCT [1] and one cross-over RCT [7], both of poor quality, reported on the efficacy of BFR in reducing examination anxiety compared with placebo. Both Armstrong and Ernst [1] and Walach et al. [7] found BFR to be no more effective than placebo. Walach et al. found no significant difference between the experimental group and the placebo group for a reduction in test anxiety. The mean reduction in anxiety score in the BFR group was 5.25, and the mean reduction in the placebo group 7.69 (P=0.55). However, flawed randomisation (randomisation was carried out using a list of random numbers, divided at the median) exposed the study to selection bias. Armstrong and Ernst [1] found no significant difference in the State anxiety score on the night before the examination most likely to cause anxiety between experimental and placebo groups: The score was 51.5 in the BFR group and 54.4 in the placebo group (P=0.834). However, this study suffered an extremely high drop-out rate of 55%, thus exposing the study to selection bias. Thus the treatment effect is consistent across the two studies, but methodological flaws found in both studies may have biased the results. The strength of the evidence is low. 4.2.2 Efficacy of Bach flower remedies for Attention-deficit Hyperactivity Disorder One poor quality RCT [8] reported on the efficacy of BFR in treating ADHD. Pintov et al. [8] found that the effect of BFR on improving ADHD was not significantly different from that of a placebo, by comparing Conner s questionnaire scores between an experimental and a placebo group. The mean Conner s score before treatment was 16.59 in the BFR group and 17.12 in the placebo group. After the treatment the corresponding values were 11.90 and 13.58. Pintov et al. reported that there was no significant difference between the groups before or after treatment, but not P-values were given. However, there was a very high dropout rate (42.5%) potentially creating selection bias. Further RCTs of good quality are necessary to determine whether this is a true reflection of the effect of BFR on ADHD. There is only one study with large methodological flaws for this population, thus the strength of the evidence is very low. 16 LBI-HTA 2008

Data extraction 4.2.3 Efficacy of BFR for pain relief No evidence. no evidence on BFR for pain relief 4.3 Safety One of the included studies [8] failed to make reference to the safety of BFRs, which may be a reflection of the fact that BFRs are generally regarded as a safe treatment. Armstrong and Ernst [1] reported two cases of headaches and some skin eruptions, while Walach et al. [7] report that one subject had adverse reactions to the Bach flower remedies, without specifying these events any further. It seems likely that BFR are a safe form of treatment, but further studies reporting the side effects of the BFR are required in order to establish their safety. likely that BFR are safe further studies required LBI-HTA 2008 17

5 Strength of the Evidence The GRADE system is used [9] to evaluate the strength of the evidence. GRADE uses the following classifications and definitions to evaluate the strength of the evidence. GRADE system b High: further research is very unlikely to change our confidence in the estimate of effect b Moderate: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate b Low: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate b Very low: any estimate of effect is very uncertain LBI-HTA 2008 19

Bach Flower Remedies for pain relief and psychological problems Table 5-1: Bach flower remedies evidence profile Design Methodological quality Number of studies/patients Consistency of results Directness Size of effect Other modificatory factors Strength of the collective evidence Outcome: Reduction in examination anxiety compared with control 2/161 RCT Poor 1 Yes Yes 5.25 mean reduction in anxiety score, no significant difference between treatment and placebo None Low Outcome: Connor s score compared with control 1/40 RCT Poor 2 Maybe 3 Yes 4.69 points reduction in Conner s score, no significant difference between treatment and placebo None Very low Outcome: Pain relief No evidence Outcome: Adverse events 1/100 RCT Poor 4 Maybe 3 Yes 3 experimental group subjects had side effects None Very low 1 Armstrong and Ernst: 55% dropout rate. Walach: Flawed randomisation. 2 Pintov: 42% dropout rate 3 Only 1 study 4 Armstrong and Ernst: 55% dropout rate. 20 LBI-HTA 2008

6 Conclusion The evidence about Bach Flower Remedies for psychological problems is very limited. Only three studies that fulfilled the review inclusion criteria were available. Across those studies, results were found to be consistent: BFR are not effective over and above the effects of placebo. However, the studies are of poor quality, largely to high drop-out rates and poor randomisation, and only cover two indications (examination anxiety and ADHD). No controlled prospective studies evaluating BFR for pain were available. This indicates a substantial gap in the evidence for BFR. Furthermore, reports as to the safety of BFR in the RCTs were inadequate, making a decisive conclusion as to the risks of BFR impossible. Overall then, there is little evidence about BFR for psychological problems and pain, and the evidence that does exist is of poor quality. Extensive and good quality RCTs are required to obtain a clear picture as to whether BFR are effective for psychological problems or pain, and the risks associated with them. very limited evidence consistent results: BFR not more effective than placebo no evidence about BFR for pain inadequate evidence about safety of BFR extensive and good quality RCTs required LBI-HTA 2008 21

7 References [1] Cate P. An ABC of alternative medicine: Bach flower remedies. Health Visit. 1986 Sep;59(9):276-7. [2] Howard J. Do Bach flower remedies have a role to play in pain control? A critical analysis investigating therapeutic value beyond the placebo effect, and the potential of Bach flower remedies as a psychological method of pain relief. Complement Ther Clin Pract. 2007 Aug;13(3):174-83. [3] Armstrong NC, Ernst E. A randomized, double-blind placebocontrolled trial of a Bach Flower Remedy. Complementary Therapies in Nursing & Midwifery. 2001 Nov;7(4):215-21. [4 ] Ernst E. "Flower remedies": a systematic review of the clinical evidence. Wien Klin Wochenschr. 2002 Dec 30;114(23-24):963-6. [5] LaTorre MA. Integrative perspectives. Integrating Bach flower remedies into a therapeutic practice. Perspect Psychiatr Care. 2006 May;42(2):140-3. [6] Methodological handbook for systematic Reviews. Internal Manual of the LBI-HTA. http://hta.lbg.ac.at/media/pdf/internes%20manual.pdf [7] Walach H, Rilling C, Engelke U. Bach-Flower remedies are ineffective for test-anxiety: results of a blinded, placebo-controlled, randomized trial. 15th Annual Meeting of the International Society of Technology Assessment in Health Care. 1999 Jun 20-23:151. [8] Pintov S, Hochman M, Livne A, Heyman E, Lahat E. Bach flower remedies used for attention deficit hyperactivity disorder in children--a prospective double blind controlled study. Europ J Paediatr Neurol. 2005;9(6):395-8. [9] Grading quality of evidence and strength of recommendations. GRADE Working Group. BMJ 2004;328:1490 http://www.bmj.com/cgi/content/full/328/7454/1490 LBI-HTA 2008 23